Please login to the form below
17
Revenue 2017Stelara
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Stelara was produced by Johnson & Johnson.
UK, Germany back routine use of J&J’s Tremfya
Tremfya (guselkumab) is a follow-up to J&J’s IL-23/IL-12 inhibitor Stelara (ustekinumab) that rakes in blockbuster revenues but is facing the threat of competition from newer ... Stelara was a $4bn product for J&J’s Janssen Pharma unit last year, but
Sun Pharma passes milestone with novel psoriasis drug approval
Johnson &Johnson's IL-12/IL-23 blocker Stelara (ustekinumab) was the first interleukin drug to reach the market and swiftly reached blockbuster sales level, and has since been joined by
AbbVie reports more solid data for would-be psoriasis blockbuster
AbbVie reports more solid data for would-be psoriasis blockbuster. Risankizumab showed to be more effective in plaque psoriasis patients than J&J’s Stelara. ... A pair of phase III trials pitting risankizumab against Johnson &Johnson’s older
Janssen’s Tremfya cleared for European use
therapy. The drug is a follow-up for its IL-23/IL-12 inhibitor Stelara, which is facing competition from newer psoriasis drugs showing greater efficacies in clinical trials.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Science Writer – Healthcare Advertising
-
Salary TBC
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
Subscribe to our email news alerts
- Johnson and Johnson’s second-in-command announces retirement plans
- Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched
- J&J says real-world data finds no amputation risk for Invokana
- Pivotal data sets up Tecentriq filing in small cell lung cancer
- New agency launched
- What pharma marketers can learn from growth hacking?
PMHub
VCCP Health
We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...
Latest intelligence
- ‘How is your day?’
- The initiative that shows how plasma protein therapies improve lives...
- Advancing women in healthcare
- Fostering the next generation of leaders...
- The Challenges Of UX In Healthcare: Technology To Change Lives
- Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....
Quick links
Infographics
